174 related articles for article (PubMed ID: 26504364)
1. 25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression.
Ene CD; Anghel AE; Neagu M; Nicolae I
Mediators Inflamm; 2015; 2015():904876. PubMed ID: 26504364
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.
Timerman D; McEnery-Stonelake M; Joyce CJ; Nambudiri VE; Hodi FS; Claus EB; Ibrahim N; Lin JY
Oncotarget; 2017 Jan; 8(4):6873-6882. PubMed ID: 28036288
[TBL] [Abstract][Full Text] [Related]
3. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
6. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.
Nürnberg B; Gräber S; Gärtner B; Geisel J; Pföhler C; Schadendorf D; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3669-74. PubMed ID: 19667163
[TBL] [Abstract][Full Text] [Related]
7. Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, São Paulo, Brazil.
de Souza WN; Norde MM; Oki É; Rogero MM; Marchioni DM; Fisberg RM; Martini LA
Nutr Res; 2016 Jan; 36(1):1-8. PubMed ID: 26773775
[TBL] [Abstract][Full Text] [Related]
8. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
9. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
Franzke A; Probst-Kepper M; Buer J; Duensing S; Hoffmann R; Wittke F; Volkenandt M; Ganser A; Atzpodien J
Br J Cancer; 1998 Jul; 78(1):40-5. PubMed ID: 9662248
[TBL] [Abstract][Full Text] [Related]
10. Serum lactate dehydrogenase is a predictor of poor survival in malignant melanoma.
Gao D; Ma X
Panminerva Med; 2017 Dec; 59(4):332-337. PubMed ID: 27309261
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma.
Hoejberg L; Bastholt L; Johansen JS; Christensen IJ; Gehl J; Schmidt H
Melanoma Res; 2012 Aug; 22(4):287-93. PubMed ID: 22617301
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study.
Kubesch A; Quenstedt L; Saleh M; Rüschenbaum S; Schwarzkopf K; Martinez Y; Welsch C; Zeuzem S; Welzel TM; Lange CM
PLoS One; 2018; 13(11):e0207162. PubMed ID: 30408125
[TBL] [Abstract][Full Text] [Related]
13. High-dose vitamin D
Smith EM; Alvarez JA; Kearns MD; Hao L; Sloan JH; Konrad RJ; Ziegler TR; Zughaier SM; Tangpricha V
Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475
[TBL] [Abstract][Full Text] [Related]
14. Increased level of circulating U2 small nuclear RNA fragments indicates metastasis in melanoma patients.
Kuhlmann JD; Wimberger P; Wilsch K; Fluck M; Suter L; Brunner G
Clin Chem Lab Med; 2015 Mar; 53(4):605-11. PubMed ID: 25741740
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
[TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
19. Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma.
Diem S; Kasenda B; Spain L; Martin-Liberal J; Marconcini R; Gore M; Larkin J
Br J Cancer; 2016 Feb; 114(3):256-61. PubMed ID: 26794281
[TBL] [Abstract][Full Text] [Related]
20. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma.
Deichmann M; Benner A; Bock M; Jäckel A; Uhl K; Waldmann V; Näher H
J Clin Oncol; 1999 Jun; 17(6):1891-6. PubMed ID: 10561230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]